It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She ...

Johnson & Johnson MedTech has concluded subject enrolment for the pilot phase of the OMNY-AF study of the investigational OMNYPULSE Platform for treating symptomatic paroxysmal atrial fibrillation ...

Johnson & Johnson MedTech today announced the completed enrollment of the pilot phase of a clinical trial for its Omnypulse ...

Larry Jones, Johnson & Johnson Medtech’s chief information officer, will resign after more than three decades with the ...

Johnson & Johnson MedTech’s Abiomed announced that its compressible, expandable heart pump has cleared a pivotal trial, and ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Shockwave Medical, Inc., part of Johnson & Johnson MedTech has announced the completion of enrollment in EMPOWER CAD, the ...

The company has predicted the narrower Impella ECP will be easier to insert and implant, as well as enable the use of small ...

Maria Sainz offers advice for medical device developers from her decades-long career in medtech C-suites and boardrooms.

Let me take a moment to congratulate our award winners for 2024. Our Visionary Award was presented to Walmart. Squint received the Start-Up Award.

A large-scale, randomized trial of the orbital atherectomy system Abbott picked up last year failed to show that it could ...